By Katherine Hamilton
Hong Kong Pharma Digital Technology Holdings closed its initial public offering of 1.4 million shares.
The over-the-counter pharmaceutical services company priced the IPO at $4 a share.
Shares began trading on Nasdaq on Jan. 15 under the symbol HKPD, the company said.
The aggregate gross proceeds from the offering were about $5.6 million before deducting underwriting discounts. Hong Kong Pharma plans to use proceeds to develop its supply chain enterprise resource planning systems, procure warehouse equipment to improve efficiency, expand its sales and marketing team, and fund general working capital.
The company has also granted underwriters a 45-day option to purchase up to 150,000 shares to cover over-allotments at the IPO price.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
January 16, 2025 14:40 ET (19:40 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。